Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this joint announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this joint announcement.

WANG ON GROUP LIMITED

WAI YUEN TONG MEDICINE

( 宏安集團有限公司) *

HOLDINGS LIMITED

(Incorporated in Bermuda with limited liability)

( 位元堂藥業控股有限公司* )

(Stock Code: 1222)

(Incorporated in Bermuda with limited liability)

(Stock Code: 897)

JOINT ANNOUNCEMENT

DELAY IN DESPATCH OF CIRCULAR

Reference is made to the joint announcement dated 26 September 2019 (the "Joint Announcement") jointly published by, amongst others, Wang On Group Limited ("WOG") and Wai Yuen Tong Medicine Holdings Limited ("WYT") in relation to, among other things, the Partial Offers and the Loan Agreement which constitute (i) major transactions for WOG; and (ii) a very substantial acquisition (in respect of the Partial Offers) and a major transaction (in respect of the Loan Agreement) for WYT. Unless otherwise stated, capitalised terms used herein shall have the same meanings as ascribed to them in the Joint Announcement.

It was disclosed in the Joint Announcement that the WOG Circular and the WYT Circular containing further information regarding, among other things, the Partial Offers and the Loan, are expected to be despatched respectively to the WOG Shareholders and the WYT Shareholders on or before 21 October 2019. As additional time is required for WYT and WOG to prepare and finalise certain financial information (including the pro forma financial information required to be disclosed under the Listing Rules) to be incorporated into the respective circulars, it is expected that the despatch of the WOG Circular and the WYT Circular will be postponed to a date on or before 4 November 2019.

By Order of the WOG Board

By Order of the WYT Board

WANG ON GROUP LIMITED

WAI YUEN TONG MEDICINE

(宏安集團有限公司)*

HOLDINGS LIMITED

Tang Ching Ho

(位元堂藥業控股有限公司*

Chairman

Tang Ching Ho

Chairman and Managing Director

Hong Kong, 21 October 2019

* For identification purpose only

- 1 -

As at this joint announcement date, the WOG Board comprises Mr. Tang Ching Ho, Ms. Yau Yuk Yin and Mr. Chan Chun Hong, Thomas as executive directors; and Dr. Lee Peng Fei, Allen, Mr. Wong Chun, Justein and Mr. Siu Kam Chau as independent non-executive directors.

As at this joint announcement date, the WYT Board comprises Mr. Tang Ching Ho, Mr. Chan Chun Hong, Thomas, Ms. Tang Mui Fun and Ms. Tang Wai Man as executive directors; and Mr. Leung Wai Ho, Mr. Siu Man Ho, Simon, Mr. Cho Wing Mou and Mr. Li Ka Fai, David as independent non-executive directors.

- 2 -

Attachments

  • Original document
  • Permalink

Disclaimer

Wang On Group Limited published this content on 21 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 October 2019 10:55:08 UTC